相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients
Takahiko Kawate et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease
Kathrine Rugbjerg et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Parkinson disease, cancer, and LRRK2 Causation or association?
Oliver Bandmann et al.
NEUROLOGY (2012)
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
R. Inzelberg et al.
NEUROLOGY (2012)
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease
R. Inzelberg et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
Brendan D. Looyenga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Increased Melanoma Risk in Parkinson Disease A Prospective Clinicopathological Study
John M. Bertoni et al.
ARCHIVES OF NEUROLOGY (2010)
LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea
Helene Plun-Favreau et al.
PLOS GENETICS (2010)
The Roco protein family:: a functional perspective
Ignacio Marin et al.
FASEB JOURNAL (2008)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
